This inventor holds 8 USPTO granted patents. Top assignee: Bayer Aktiengesellschaft. Active years: 1978-1981.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1978-1981
Title: The Innovations of Karl-August Meng
Introduction
Karl-August Meng was a notable inventor whose contributions to the field of pharmaceuticals have left a lasting impact. He was based in Wuppertal, Germany, and held a total of 8 patents during his career. His work primarily focused on the development of novel compounds with significant therapeutic applications.
Latest Patents
Among his latest patents, Meng developed imidazo[2,1-b]-[1,3,4]-thiadiazole compounds. This invention relates to new imidazo[2,1-b]-[1,3,4]-thiadiazole compounds, which are utilized in pharmaceutical compositions. These compounds are particularly noteworthy for their use as antithrombotic and thrombolytic agents. Another significant patent involved 4-substituted pyrazoles, which are characterized by a specific chemical formula that enhances their efficacy in medical applications.
Career Highlights
Meng's career was marked by his association with Bayer Aktiengesellschaft, a leading global pharmaceutical company. His innovative work contributed to the advancement of drug development and therapeutic solutions, showcasing his expertise in medicinal chemistry.
Collaborations
Throughout his career, Meng collaborated with esteemed colleagues such as Friedel Seuter and Harald Horstmann. These partnerships fostered a creative environment that led to significant advancements in their respective fields.
Conclusion
Karl-August Meng's legacy as an inventor is defined by his innovative contributions to pharmaceutical science. His patents continue to influence the development of important medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile